ZTS Stock — Zoetis Inc.

Zoetis Inc. (ZTS)

Updated October 16, 2026.

ZTS is a Stock. its distribution rate is 2.67%, its trailing-12-month yield is 2.63%. Dividend Vision Distribution Safety Score™ is 65/100 (Generally safe). Total return is 187.6% over the past 13.7 years, 349.5 points behind SPY at 537.1%.

Zoetis is a biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines, vaccines, diagnostics, and precision health solutions for animals, serving both companion animal and livestock markets globally. The company distributes dividends quarterly at a modest current rate. Zoetis appeals to income-oriented investors seeking exposure to the animal health sector with regular dividend payments.

ZTS performance versus SPY

Price and return data through 2026-10-16.

Total return is 187.6% over the past 13.7 years, 349.5 points behind SPY at 537.1%. Over the past year its total return — price change plus distributions reinvested — is -43.5%. Its deepest 1-year drawdown was 52.3%.

ZTS key facts

Distribution Safety Score™

65 · Generally safe

Safety-Adjusted Yield

1.74%

Asset type

Stock

Asset class

Equity

Inception date

02/01/2013

Distribution rate

2.67%

Distribution frequency

Quarterly

Trailing yield

2.63%

5-year average yield

0.92

Last close

$79.38 (stale; as of 2026-10-16)

Market cap

$32,801,689,527

Average volume

5570700.0

Dividend

$0.53

Ex-dividend date

10/30/2026

Payment date

12/01/2026

Beta

0.74

Payout ratio

32.2%

P/E ratio

13.06

Forward P/E

11.9904

EPS

$6.08

How Dividend Vision calculates yield and returns

Distribution rate (2.67%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (2.63%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

ZTS risks and drawbacks

ZTS's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 52.3%.

Who may consider ZTS — and who may not

ZTS may suit someone looking for moderate current income with a quality tilt. It is a weaker fit for investors who need monthly cash flow (ZTS pays quarterly); investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on ZTS

• All tickers starting with Z

Tagged: Dividend, Pharmaceutical.

Frequently asked questions